Coronavirus update: AstraZeneca halts global vaccine trials
India, Sept. 9 -- COVID-19 has affected 19 sectors in India that were not under stress earlier, with a total Rs 15.5 lakh crore outstanding debt; retail and wholesale trade most affected
Pharmaceutical company AstraZeneca Plc halted global trials of the vaccine it was developing against the novel coronavirus disease (COVID-19) because of a serious adverse reaction in a participant, the company said September 9, 2020.
* The company said the halt was "a routine action whenever there is a potentially unexplained illness in one of the trials", reported news daily The New York Times. It is unclear till when the trial will be halted.
* AstraZeneca's share price dipped 12 per cent to Rs 3,650 in the Bombay Stock Exchange, reported Financial E...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.